News

The partnership will focus on developing three proteins, including tau, TDP-43 and an undisclosed target, implicated in the pathogenesis of various neurodegenerative diseases. Celgene will be provided with

Belimumab and rituximab have different but potentially complementary mechanisms of action. This study will assess whether co-administration enhances the treatment effect of belimumab and provides sustained disease control,

The proposed transaction will be completed pursuant to the acquisition by Cipher of all of the outstanding shares of Cardiome, following a restructuring of Cardiome pursuant to a

Adcetris is an antibody-drug conjugate (ADC) that allows the antibody to direct the drug to a target on lymphoma cells known as CD30, which is considered to be

In a Nature Microbiology paper, the researchers reported that more than a quarter of the non-antibiotics restrict the growth of at least one species in the microbiome, which

Patients receiving the 2 mg dose of etrasimod achieved statistically significant improvements versus placebo in the primary, all secondary, and clinical remission endpoints.  Relative to placebo, there was

If approved, the sNDA would expand the indication of XTANDI to include men with non-metastatic Castration-Resistant Prostate Cancer (CRPC), based on data from the Phase 3 PROSPER trial.

HTX-011, which is a combination of local anesthetic bupivacaine and anti-inflammatory meloxicam, had produced statistically significant reductions in both pain intensity and need for opioids through 72 hours post-surgery.

With funding from the DoD, Bavarian Nordic will utilize its proprietary MVA-BN platform to develop a vaccine against various strains of the virus, for which there is currently